BCAL Diagnostics Limited (ASX:BDX) Receives NATA Accreditation
BCAL Diagnostics Limited (ASX: BDX) receives NATA accreditation, advancing its BREASTEST® commercialisation efforts.
BCAL Diagnostics Limited (ASX: BDX) receives NATA accreditation, advancing its BREASTEST® commercialisation efforts.
Spark New Zealand divests remaining Connexa stake to CDPQ for $314 million, recognising a $70 million gain.
Neal Barclay will step down as CEO of Meridian Energy, with Mike Roan appointed as his successor effective June 2025.
Element 25 Limited announces significant expansion at Butcherbird Mine and the development of a US refinery for sustainable manganese supply.
Antilles Gold Limited (ASX: AAU) announces a revised scoping study for the Nueva Sabana gold-copper mine, revealing positive financial estimates and future plans.
Unico Silver Limited (ASX:USL) announces high-grade drill results from its Cerro Leon project, indicating significant silver equivalent mineralisation.
Ark Mines Limited confirms the commercial viability of its Sandy Mitchell Rare Earths Project based on positive results from a comprehensive Scoping Study.
Capitol Health announces the effective implementation of its acquisition by Integral Diagnostics, leading to trading suspension on the ASX.
LiveHire Ltd (ASX: LVH) recommended shareholders accept Humanforce’s unconditional takeover offer at $0.045 per share.
Diatreme Resources Limited (ASX: DRX) signs MOU with Mitsui & Co. to explore silica sand offtake, boosting its development in Queensland.